Alvogen Reshaped By A Year Of Change
Group Positioned For Future By Sale Of CEE Business And Adalvo B2B Rebranding
After a year that has seen Alvogen divest its central and eastern Europe business to Zentiva and rebrand its B2B unit as Adalvo, the group has also demonstrated the resilience of its supply chain in the face of upheaval caused by the coronavirus pandemic, chairman and CEO Robert Wessman tells Generics Bulletin in the second part of an exclusive interview.
